Knee treatment co Apos raises $8m (Globes Israel Business)
The company, which has developed a device for the treatment of knee osteoarthritis by creating multi-directional instability, raised the money from Pitango.
Apos Medical and Sports Technology Ltd., which has developed a device for the treatments of knee osteoarthritis, has raised $8 million from Pitango Venture Capital in its first financing round. Apos previously raised $12 million from private investors and Invus Group LLC.
Apos's product is a platform attached to a person's shoes to create multi-directional instability in walking to mimic natural walking on uneven surfaces, thereby strengthening the muscles and alleviating pain. Treatments take 30-60 minutes a day.
Apos CEO Dr. Amit Mor says, "The product has several applications. It can be used for stabilization, improve athletes' performance, and prevent knee injury. We initially targeted the knee injury market, which is a huge market, both in terms of the patients and the economic burden to the health system."
The product can also treat knee damage caused by aging, or injuries from sports or accidents. In both cases, current treatments are based on pa...
